AnaptysBio Inc (ANAB): Total Asset Value of Company
The financial stability of AnaptysBio, Inc. (ANAB) is subject to the outcomes of clinical trials and reliance on partner payments, as confirmed by this price chart on GURU.Markets, where total assets amount to 276.52. Base growth relies on the creation of innovative antibodies against dermatitis that are close to market entry. Business development is based on a unique biological platform that generates a pipeline of molecules within a closed patent perimeter.
Comprehensive metric breakdowns and analytics for AnaptysBio Corp (ANAB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:ANAB, anaptysbio.com
AnaptysBio, Inc. (ANAB) development of innovative treatments for immune pathologies is directly reflected in the calculation of total assets, which captures the overall value of the company's resources. This indicator, calculated inversely via return on assets (ROA), allows for an assessment of capital management efficiency, including cash and royalties from GSK, to differentiate organic business growth from risky balance sheet expansion driven by debt obligations.
Competitors of AnaptysBio, Inc. (ANAB)
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|Company Assets Pieris Pharma PVLA|Savara Corp - Company Total Assets|RIGL: Company Total Assets|Aggregate Company Assets Astria Therapeutics|engene.com (ENGN) - Total Business Assets|RAPT (RAPT Therapeutics) - Company Total Assets|Company Total Assets JBIO|ACRS - Aggregate Company Assets|Total Asset Value of Company Kyverna Therapeutics, Inc KYTX|Cumulative Company Assets Tiziana Life Sciences (TLSA)|CABA - Aggregate Business Assets|VTYX (Ventyx Biosciences, Inc.) - Cumulative Company Assets|THTX: Company Assets|Avalo Therapeutics Inc. - Aggregate Company Assets|Eledon Pharmaceuticals, Inc (ELDN) - Company Total Asset Base|Company Total Assets Agenus|Aggregate Company Assets climbbio.com|ZURA (Zura Bio) - Company Total Assets|Company Total Asset Base ATYR (aTyr Pharma Inc)|ADAG: Aggregate Company Assets|IMA - Company Assets|Cumulative Company Assets Shattuck Therapeutics (STTK)|EQ - Aggregate Asset Value|connectbiopharm.com - Company Total Assets|IMUX (Immunic) - Company Total Asset Base|Aggregate Company Assets Atara Biotherapeutics, Inc. (ATRA)|Total Business Assets InflaRx GmbH|Company Total Assets XFOR (X4 Pharmaceuticals)|Cumulative Company Assets adicetbio.com ACET|Cumulative Company Assets CELU|Company Total Asset Base INmune Bio Inc INMB|Barinthus Bio - Company Total Assets|KZR: Company Total Assets|Aggregate Company Assets SAB Biotherapeutics|akaritx.com (AKTX) - Total Business Assets|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Company Total Assets Q32 Bio Corp|Company Total Assets GeoVax Labs Inc (GOVX)|Aggregate Company Assets EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Aggregate Company Assets|Total Asset Value of Company Carisma Therapeutics Inc CARM|Company Total Assets XTL Biopharmaceuticals Ltd. (XTLB)|BOLT - Aggregate Asset Value|HCWB: Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Company Total Assets|AIM - Aggregate Company Assets|Aggregate Asset Value ADTX|Aggregate Company Assets GRI (GRI Bio)|Cumulative Company Assets XORTX Therapeutics Inc (XRTX)|Company Total Assets HIND (ReShape Lifesciences)|REVB - Company Total Assets|Cumulative Company Assets Indaptus Therapeutics (INDP)|SCNI - Aggregate Asset Value|calcimedica.com - Company Total Assets|AFMD (Affimed N.V.) - Company Total Asset Base|Aggregate Company Assets ALLK|Cumulative Company Assets HOOK|Aggregate Company Assets IGMS (IGM Biosciences, Inc.)|Cumulative Company Assets iteostherapeutics.com ITOS|Cumulative Company Assets OCEA (Ocean Biomedical)|TC BioPharm (Holdings) Plc - Company Total Assets|Third Harmonic Bio, Inc (THRD) - Aggregate Company Assets